|
|
Volumn 23, Issue 2, 2017, Pages 138-140
|
|
Channeling chip power: Tissue chips are being put to the test by industry
a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
FLUORESCENT DYE;
SILICON;
BIOTECHNOLOGY;
CAPILLARY;
DECISION MAKING;
DRUG DEVELOPMENT;
DRUG INDUSTRY;
DRUG SCREENING;
EXPERIMENTAL MODEL;
HUMAN;
INDUCED PLURIPOTENT STEM CELL;
INFORMATION;
KIDNEY;
KIDNEY CELL;
MICROENVIRONMENT;
MOLECULE;
NATIONAL HEALTH ORGANIZATION;
NONHUMAN;
PRIORITY JOURNAL;
SCIENTIST;
SHORT SURVEY;
STANDARD;
TISSUES;
TOXICITY;
VALIDATION PROCESS;
VASCULARIZATION;
ARTIFICIAL CELL;
BIOARTIFICIAL ORGAN;
DEVICES;
INVENTION;
LAB ON A CHIP;
MICROELECTROMECHANICAL SYSTEM;
ORGANIZATION;
ORGANIZATION AND MANAGEMENT;
PROCEDURES;
TRENDS;
ARTIFICIAL CELLS;
BIOARTIFICIAL ORGANS;
BIOTECHNOLOGY;
CONGRESSES AS TOPIC;
DRUG INDUSTRY;
HUMANS;
INVENTIONS;
KIDNEY;
LAB-ON-A-CHIP DEVICES;
MICRO-ELECTRICAL-MECHANICAL SYSTEMS;
|
|
EID: 85011838444
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm0217-138 Document Type: Short Survey |
|
Times cited : (11)
|
|
References (0)
|
